Cooperation between Russia and Switzerland in the pharmaceutical industry

The article analyzes the priority areas of cooperation between Russia and Switzerland in the pharmaceutical industry. This topic is of interest, since the pharmaceutical industry is quite an important component of the healthcare system around the world. However, this industry requires significant costs and resources. It is important to note that more than 60% of spending is spent on R&D. The industry participants are numerous public and private structures whose purpose is to conduct research, as well as the production and sale of medicines. Russia faces an important task of creating a modern economy based on the priority formation of high-tech industries. And Switzerland, one of the most highly developed countries in the world, remains important for Russia as a reliable partner in the pharmaceutical industry.